Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Leerink Partners Initiates Coverage On Dentsply Sirona with Outperform Rating, Announces Price Target of $42

Author: Benzinga Newsdesk | February 26, 2024 09:26am
Leerink Partners analyst Michael Cherny initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Outperform rating and announces Price Target of $42.

Posted In: XRAY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist